Real-time data improves visibility and speeds up issue detection, reducing downtime and delays. Live metrics enable faster, more effective production decisions and help optimize performance on the ...

Modern business intelligence demands speed, and utilizing AI tools for Excel is the ultimate way to hyper-charge your data workflows this year.

Explains how to quickly import and manage real-time data in Excel using data types, highlighting steps and practical tips for efficiency. #ExcelTips #DataTypes #Productivity Trump is spending $5M in ...

Centerspace’s strategic review is set to result in a sale of 20 percent of the apartment landlord’s portfolio. The North Dakota-based multifamily real estate investment trust announced plans this week ...

Building Equity Management doesn’t appear to be ready to tip its hand, but its latest acquisition is further proof that it has something in the works in Nolita. Michael Vinocur’s firm bought the ...

The Florida Python Challenge brings out a fascinating cast of characters, all captured by the director Xander Robin’s camera. By Alissa Wilkinson When you purchase a ticket for an independently ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.